drugset / Trial / NCT00815685
A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia
NaSingle-groupOpen-labelTreatment
Summary
The data collected through this pilot study will allow us to increase our understanding of cancer cachexia and the effect of Eicosapentaenoic Acid (EPA) on cancer cachexia. Our long-term goal is to improve nutritional treatment and reduce illness in the cancer patient population.
Timeline
- Start
- 2007-07
- Primary completion
- 2010-03
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eicosapentaenoic acid | Small molecule | 4 g | — |
Indications
No indication recorded.